Danone S.A. (DANOY) Income Statement Analysis

See more : CENTRAL MOTEK Co.Ltd. (308170.KS) Income Statement Analysis – Financial Results

Complete financial analysis of Danone S.A. (DANOY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Danone S.A., a leading company in the Packaged Foods industry within the Consumer Defensive sector.

You may be interested

Protocall Technologies Inc. (PCLI) Income Statement Analysis – Financial Results
Gujarat State Petronet Limited (GSPL.NS) Income Statement Analysis – Financial Results
Hunt Companies Acquisition Corp. I (HTAQ-WT) Income Statement Analysis – Financial Results
Bankinvest – Danske Aktier Akk. KL (BAIDKAAKA.CO) Income Statement Analysis – Financial Results
Castings P.L.C. (CGS.L) Income Statement Analysis – Financial Results

Danone S.A. (DANOY)

Industry: Packaged Foods

Sector: Consumer Defensive

Website: https://www.danone.com

About Danone S.A.

Danone S.A. operates in the food and beverage industry in Europe, Noram, Latin America, the Asia Pacific, Africa, and the Middle East. The company operates through three segments: Essential Dairy & Plant-Based, Specialized Nutrition, and Waters. It produces and distributes yogurts; milk products; coffee creamers, drinks, and beverages; plant-based products; and ice creams, desserts, and nutritional powdered protein products under the Actimel, Activia, Alpro, Aptamil, Danette, Danio, Danonino, evian, Nutricia, Nutrilon, Volvic, as well as under the licensed brands, including International Delight, Dunkin' Donuts, and Bailey's. The company also offers specialized nutrition products for pregnant and breastfeeding mothers, infants, and young children under the Aptamil, Nutrilon, Gallia, Cow & Gate, Blédina, Bebelac, Olvarit, and Happy Family Organics brands. In addition, it provides tube feeding products under the Nutrison name; oral nutritional supplements under the Fortimel and NutriDrink names; and hypoallergenic products for children with allergies primarily under the Aptamil ProSyneo, Aptamil Pepti Syneo, and Neocate Syneo names. Further, the company offers water with natural fruit extracts, fruit juice, and vitamins under the evian, Volvic, Aqua, Mizone, Bonafont, Villavicencio, Villa del Sur, Hayat, Sirma, Fontvella, Lanjarón, Salus, Aqua d'Or, and Zywiec Zdroj brands. It distributes its products through retail chains and traditional market outlets; convenience stores; hospitals, clinics, and pharmacies; and e-commerce. The company was formerly known as Groupe Danone and changed its name to Danone S.A. in April 2009. Danone S.A. was incorporated in 1899 and is headquartered in Paris, France.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997
Revenue	27.62B	27.66B	24.28B	23.62B	25.29B	24.65B	24.68B	21.94B	22.41B	21.14B	21.30B	20.87B	19.32B	17.01B	14.98B	15.22B	12.78B	14.07B	13.01B	13.69B	13.11B	13.57B	14.50B	14.33B	13.33B	12.92B	13.35B
Cost of Revenue	14.54B	14.92B	12.76B	12.27B	12.88B	12.73B	12.46B	10.74B	11.21B	11.06B	10.98B	10.41B	9.54B	7.96B	6.75B	7.17B	6.38B	7.21B	6.64B	6.36B	5.97B	6.45B	7.43B	7.23B	6.04B	6.10B	6.66B
Gross Profit	13.08B	12.74B	11.52B	11.35B	12.41B	11.92B	12.22B	11.20B	11.20B	10.09B	10.32B	10.46B	9.78B	9.05B	8.23B	8.05B	6.40B	6.86B	6.38B	7.33B	7.14B	7.12B	7.07B	7.10B	7.29B	6.82B	6.69B
Gross Profit Ratio	47.37%	46.05%	47.45%	48.07%	49.07%	48.36%	49.51%	51.04%	49.97%	47.71%	48.46%	50.12%	50.61%	53.21%	54.95%	52.88%	50.06%	48.74%	48.99%	53.51%	54.43%	52.48%	48.75%	49.54%	54.71%	52.81%	50.10%
Research & Development	398.00M	339.00M	338.00M	323.00M	351.00M	335.00M	342.00M	333.00M	307.00M	272.00M	275.00M	257.00M	233.00M	209.00M	206.00M	198.00M	121.00M	126.00M	123.27M	130.57M	129.43M	133.42M	125.88M	125.64M	122.24M	120.14M	114.36M
General & Administrative	2.75B	2.64B	2.33B	2.29B	2.39B	2.22B	2.23B	2.00B	1.94B	1.74B	1.71B	1.75B	1.56B	1.49B	1.36B	1.30B	943.00M	1.05B	4.34B	5.29B	5.14B	5.14B	5.33B	5.42B	5.02B	4.50B	4.41B
Selling & Marketing	6.29B	6.29B	5.52B	5.37B	5.77B	5.64B	5.89B	5.56B	5.68B	5.21B	5.43B	5.47B	5.09B	4.66B	4.21B	4.20B	3.50B	3.61B	-3.11B	3.11B	-4.33B	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	9.04B	8.93B	7.84B	7.65B	8.16B	7.86B	8.12B	7.57B	7.62B	6.95B	7.13B	7.22B	5.09B	6.16B	5.57B	5.49B	4.44B	4.65B	4.34B	5.29B	5.14B	5.14B	5.33B	5.42B	5.02B	4.50B	4.41B
Other Expenses	1.61B	53.00M	39.00M	44.00M	95.00M	60.00M	62.00M	-23.00M	-64.00M	-16.00M	-221.00M	-6.00M	67.00M	107.00M	-77.00M	169.00M	288.00M	135.00M	202.63M	-239.01M	-227.09M	264.93M	-654.12M	59.63M	760.25M	701.14M	728.27M
Operating Expenses	11.04B	9.32B	8.22B	8.02B	8.60B	9.23B	8.49B	8.22B	8.21B	7.46B	7.47B	7.54B	7.05B	6.47B	5.94B	5.86B	4.85B	4.91B	4.67B	5.62B	5.53B	5.53B	5.45B	5.54B	5.90B	5.32B	5.26B
Cost & Expenses	25.58B	24.25B	20.98B	20.29B	21.48B	21.95B	20.95B	18.96B	19.42B	18.52B	18.45B	17.94B	16.59B	14.43B	12.69B	13.03B	11.23B	12.13B	11.31B	11.99B	11.51B	11.98B	12.88B	12.77B	11.94B	11.42B	11.92B
Interest Income	156.00M	155.00M	156.00M	151.00M	181.00M	162.00M	151.00M	130.00M	122.00M	94.00M	76.00M	75.00M	67.00M	87.00M	76.00M	58.00M	132.00M	182.00M	88.00M	55.00M	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	513.00M	308.00M	323.00M	358.00M	400.00M	393.00M	414.00M	276.00M	274.00M	274.00M	269.00M	245.00M	241.00M	230.00M	264.00M	497.00M	307.00M	219.00M	189.00M	149.00M	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation & Amortization	1.61B	1.86B	1.27B	1.45B	1.39B	863.00M	830.00M	754.00M	1.22B	956.00M	710.00M	670.00M	-46.00M	594.00M	549.00M	525.00M	420.00M	491.00M	477.88M	558.42M	597.90M	721.40M	778.87M	759.16M	760.25M	701.14M	728.27M
EBITDA	3.81B	4.00B	3.58B	4.30B	4.65B	4.39B	4.68B	3.69B	3.42B	3.07B	3.47B	3.36B	3.31B	2.52B	2.91B	2.57B	2.10B	2.52B	2.26B	2.20B	2.20B	2.31B	2.39B	2.31B	2.16B	2.21B	2.16B
EBITDA Ratio	13.79%	18.36%	19.18%	20.41%	20.69%	17.85%	19.21%	16.98%	18.44%	16.70%	15.25%	16.26%	14.13%	19.48%	18.92%	17.25%	16.41%	18.39%	16.77%	16.53%	16.78%	17.05%	16.49%	16.15%	16.17%	17.07%	16.18%
Operating Income	2.04B	3.22B	3.39B	2.80B	3.24B	2.74B	3.73B	2.92B	2.21B	2.15B	2.13B	2.75B	2.73B	2.58B	2.51B	2.19B	1.55B	1.87B	1.70B	1.70B	1.60B	1.59B	1.61B	1.55B	1.40B	1.50B	1.43B
Operating Income Ratio	7.39%	11.62%	13.97%	11.85%	12.80%	11.12%	15.13%	13.32%	9.86%	10.17%	9.99%	13.16%	14.13%	15.16%	16.76%	14.37%	12.10%	13.32%	13.10%	12.45%	12.22%	11.73%	11.12%	10.85%	10.47%	11.64%	10.73%
Total Other Income/Expenses	-321.00M	-311.00M	-262.00M	-310.00M	-370.00M	-348.00M	-437.00M	-293.00M	-285.00M	-312.00M	-263.00M	-329.00M	-294.00M	-20.00M	-489.00M	-584.00M	-177.00M	-68.00M	-110.00M	-33.48M	-276.32M	183.92M	-1.06B	-268.31M	-210.68M	-473.91M	-432.64M
Income Before Tax	1.72B	1.83B	2.00B	2.49B	2.87B	2.39B	3.30B	2.63B	1.93B	1.84B	1.87B	2.45B	2.44B	2.49B	2.02B	1.60B	1.37B	1.81B	1.59B	1.53B	1.33B	1.78B	549.59M	1.29B	1.18B	1.03B	999.91M
Income Before Tax Ratio	6.23%	6.62%	8.22%	10.53%	11.34%	9.71%	13.36%	11.99%	8.59%	8.70%	8.76%	11.72%	12.60%	14.63%	13.50%	10.53%	10.72%	12.83%	12.26%	11.14%	10.11%	13.09%	3.79%	8.98%	8.89%	7.97%	7.49%
Income Tax Expense	768.00M	778.00M	589.00M	762.00M	793.00M	716.00M	842.00M	804.00M	626.00M	599.00M	604.00M	712.00M	626.00M	576.00M	424.00M	443.00M	410.00M	360.00M	472.81M	456.62M	487.53M	490.78M	416.97M	563.25M	500.87M	432.98M	447.00M
Net Income	881.00M	959.00M	1.41B	1.96B	1.92B	2.34B	2.45B	1.72B	1.28B	1.12B	1.42B	1.67B	1.67B	1.88B	1.36B	1.31B	4.18B	1.35B	1.46B	316.46M	837.70M	1.28B	132.62M	722.96M	683.73M	597.37M	552.91M
Net Income Ratio	3.19%	3.47%	5.79%	8.28%	7.57%	9.47%	9.92%	7.84%	5.72%	5.29%	6.68%	8.01%	8.65%	11.02%	9.08%	8.63%	32.72%	9.61%	11.25%	2.31%	6.39%	9.47%	0.91%	5.05%	5.13%	4.62%	4.14%
EPS	1.35	1.48	2.18	2.99	2.95	0.73	0.78	0.56	0.42	0.38	0.48	0.56	0.55	0.61	0.48	0.53	1.75	0.56	0.60	0.13	0.33	0.49	0.05	0.26	0.24	0.21	0.20
EPS Diluted	1.36	1.48	2.17	2.99	2.95	0.73	0.78	0.56	0.42	0.38	0.48	0.55	0.55	0.61	0.48	0.53	1.74	0.55	0.59	0.12	0.32	0.47	0.05	0.26	0.24	0.20	0.19
Weighted Avg Shares Out	647.79M	639.05M	646.16M	649.33M	648.25M	3.21B	3.13B	3.08B	3.05B	2.97B	2.94B	3.00B	3.01B	3.07B	2.83B	2.46B	2.38B	2.43B	2.46B	2.51B	2.55B	2.64B	2.79B	2.81B	2.79B	2.80B	2.83B
Weighted Avg Shares Out (Dil)	641.74M	639.48M	646.45M	649.97M	649.11M	3.22B	3.14B	3.08B	3.05B	2.98B	2.94B	3.02B	3.02B	3.08B	2.83B	2.47B	2.40B	2.45B	2.50B	2.58B	2.63B	2.74B	2.85B	2.83B	2.97B	2.92B	2.93B

After two-year wait, Danone gears up for Olympics health-kick ahead of Paris Games

April 18, 2024reuters.com

Danone, whose CEO first reached out to the International Olympic Committee (IOC) in mid-2022 to get involved, is betting on the Paris Games' focus on health and nutrition to boost summer sales of its yoghurts and plant-based products.

Danone beats first-quarter sales forecasts, keeps 2024 goals

April 18, 2024reuters.com

Danone posted stronger-than-expected quarterly sales on Thursday, with all businesses delivering volume growth as the world's largest yoghurt maker managed to raise prices to cope with higher input costs though at a slower pace than previously.

Danone Backs Outlook as Sales, Volumes Beat Estimates

April 18, 2024wsj.com

Danone said it expected like-for-like sales growth of between 3% and 5% in 2024, and confirmed it anticipated a moderate improvement in recurring operating margin.

Danone: Good start to the year; Further delivering on Renew Danone

April 18, 2024globenewswire.com

2024 First Quarter Sales Press release – Paris, April 18, 2024 Good start to the year Further delivering on Renew Danone Net sales reached €6,789m in Q1 2024, up +4.1% on a like-for-like (LFL) basis, with volume/mix up +1.2%, and...

Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'

April 4, 2024cnbc.com

The CEO of French consumer goods giant Danone downplayed the threat of obesity drugs on its food business, arguing that consumers were likely to turn to healthy products as part of their new regime.

Danone: Convening to the Combined Shareholders' Meeting of April 25, 2024

April 3, 2024globenewswire.com

Press release – Paris, April 3, 2024 Convening to the Combined Shareholders' Meeting of April 25, 2024 Danone informs its Shareholders that its Combined Shareholders' Meeting will take place on Thursday April 25, 2024, at 2:30 pm (Paris time), at...

Danone: Update from Danone on its EDP business in Russia

March 22, 2024globenewswire.com

Press release – Paris, March 22, 2024 Update from Danone on its EDP business in Russia Danone announces today that the Russian regulatory approvals required for the disposal of its EDP business in Russia to Vamin R LLC have been...

Danone publishes its 2023 Universal Registration Document

March 12, 2024globenewswire.com

Press Release – Paris, March 12, 2024 Danone publishes its 2023 Universal Registration Document Danone filed its 2023 Universal Registration Document with the French Financial Markets Authority (Autorité des Marchés Financiers) on March 12, 2024. The 2023 Universal Registration Document...

Danone: Notification of availability of Danone's 2023 consolidated financial statements and statutory auditors' report

March 6, 2024globenewswire.com

Press Release – Paris, March 6, 2024 Notification of availability of Danone's 2023 consolidated financial statements and statutory auditors' report Danone announces that its consolidated financial statements and the statutory auditors' report for the fiscal year ended December 31, 2023...